[Urinary Incontinence in Men and Women. Diagnostics and Conservative Therapy]

Overview

Journal Urologe A

Specialty Urology

Date 2014 Jul 16

PMID 25023244

Citations 1

Authors

M F Hamann

K P Junemann

C M Naumann

Affiliations

Soon will be listed here.

Abstract

Urinary incontinence can affect men and women to the same degree. A differentiation is made between stress incontinence (i.e. urine discharge as a result of physical activities, sneezing or coughing), urge incontinence (i.e. strong urge to void with involuntary discharge of urine), mixed urinary incontinence and special forms. While men and women share the pathophysiology of urge-associated urinary incontinence, the multifactorial female urinary stress incontinence is in contrast to the stress incontinence in men which is almost exclusively caused by prostatectomy (postprostatectomy). The basic diagnostic procedure for urinary incontinence is largely non-invasive. Special diagnostic procedures are reserved for recurrences and preparation for operative measures. Therapy is oriented to the degree of suffering and patient compliance and incorporates conservative measures as first line therapy (e.g. lifestyle changes, bladder and continence training). Duloxetin is approved for the medicinal therapy of female urinary stress incontinence. The treatment of urge-associated urinary incontinence is primarily with anticholinergic agents. Alternatively, procedures for neuromodulation, a beta mimetic or injection therapy with botulinum toxin can be used in the future.

Citing Articles

The Novel and Minimally Invasive Treatment Modalities for Female Pelvic Floor Muscle Dysfunction; Beyond the Traditional.

Akin Y, Young M, Elmussareh M, Charalampogiannis N, Gozen A Balkan Med J. 2018; 35(5):358-366.

PMID: 29952311 PMC: 6158473. DOI: 10.4274/balkanmedj.2018.0869.

References

Mariappan P, Alhasso A, Ballantyne Z, Grant A, Ndow J . Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol. 2006; 51(1):67-74. DOI: 10.1016/j.eururo.2006.08.041. View

Dumoulin C, Hay-Smith J . Pelvic floor muscle training versus no treatment for urinary incontinence in women. A Cochrane systematic review. Eur J Phys Rehabil Med. 2008; 44(1):47-63. View

Fowler C, Auerbach S, Ginsberg D, Hale D, Radziszewski P, Rechberger T . OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial. Eur Urol. 2012; 62(1):148-57. DOI: 10.1016/j.eururo.2012.03.005. View

Seif C, Boy S, Wefer B, Dmochowski R, Braun P, Junemann K . [Botulinum toxin for the treatment of overactive bladder--an overview]. Urologe A. 2007; 47(1):46-53. DOI: 10.1007/s00120-007-1592-2. View

Khullar V, Amarenco G, Angulo J, Cambronero J, Hoye K, Milsom I . Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol. 2012; 63(2):283-95. DOI: 10.1016/j.eururo.2012.10.016. View

Dietz H . Pelvic floor ultrasound in incontinence: what's in it for the surgeon?. Int Urogynecol J. 2011; 22(9):1085-97. DOI: 10.1007/s00192-011-1402-7. View

Glazener C, Lapitan M . Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst Rev. 2012; 1:CD003195. DOI: 10.1002/14651858.CD003195.pub2. View

Irwin D, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S . Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006; 50(6):1306-14. DOI: 10.1016/j.eururo.2006.09.019. View

Chartier-Kastler E . Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience. BJU Int. 2007; 101(4):417-23. DOI: 10.1111/j.1464-410X.2007.07233.x. View

10.

Abrams P, Andersson K, Birder L, Brubaker L, Cardozo L, Chapple C . Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2009; 29(1):213-40. DOI: 10.1002/nau.20870. View

11.

Nomiya M, Yamaguchi O . A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol. 2003; 170(2 Pt 1):649-53. DOI: 10.1097/01.ju.0000067621.62736.7c. View

12.

Bauer R, Gozzi C, Roosen A, Khoder W, Trottmann M, Waidelich R . Impact of the 'repositioning test' on postoperative outcome of retroluminar transobturator male sling implantation. Urol Int. 2013; 90(3):334-8. DOI: 10.1159/000347123. View

13.

Chapple C, Khullar V, Gabriel Z, Muston D, Bitoun C, Weinstein D . The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008; 54(3):543-62. DOI: 10.1016/j.eururo.2008.06.047. View

14.

Bright E, Oelke M, Tubaro A, Abrams P . Ultrasound estimated bladder weight and measurement of bladder wall thickness--useful noninvasive methods for assessing the lower urinary tract?. J Urol. 2010; 184(5):1847-54. DOI: 10.1016/j.juro.2010.06.006. View

15.

Lucas M, Bosch R, Burkhard F, Cruz F, Madden T, Nambiar A . EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012; 62(6):1130-42. DOI: 10.1016/j.eururo.2012.08.047. View

16.

Cody J, Jacobs M, Richardson K, Moehrer B, Hextall A . Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012; 10:CD001405. PMC: 7086391. DOI: 10.1002/14651858.CD001405.pub3. View

17.

Nitti V, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C . OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2012; 189(6):2186-93. DOI: 10.1016/j.juro.2012.12.022. View

18.

Hay-Smith J, Morkved S, Fairbrother K, Herbison G . Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev. 2008; (4):CD007471. DOI: 10.1002/14651858.CD007471. View

19.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U . The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002; 21(2):167-78. DOI: 10.1002/nau.10052. View